Non-Hodgkin S lymph oma of the sinonasal tract is an uncommon lesion, representing 1.5 to 15% of all lymphomas. Mos t cases ofprimary non-Hodgkin 's lymphoma of the sinonasa l tract occur in the maxillary sinus, ethmoid sinus, and nasal cavity; its occ urrence in the fro ntal sinus is extremely rare. We report a case of primary type B non-Hodgkin 's lymphoma of the frontal sinus in a 43-y ear-old man. The patient complained of f rontal headaches that had not improved with analgesic drugs, and he presented with afrontal bulge that involved the left upp er eyelid; the bulge had p rogressively enlarged over a 3-month period. A biopsy ofthe mass identified the typ e B non-Hodgkin 's lymphoma. Immunohistochemical study not only confi rmed the histologic type ofthe tumor; it also provided some important information about the primary tumor site. Advances in immun ohisto chemistry have shown that type B non-Hodgkin 's lymphoma is more common in North American and European patients, whereas subtype T is more comm on in Asians and in some Latin Americans. The treatment of this condition is still controversi al, but the combination ofradiotherapy and chemotherapy has yie lded the best resul ts in all stages of the disease.
Introduction
Lymphoma accounts for 3 to 5% of all malignant tumors; non-Hodgkin 's lymphoma (NHL) accounts for 60% of all lymphomas.' >Involvementofthe nasal cavity and paranasal sinuses by these tumors is uncommon. N HL is the most common nonepithelial neopl asm of the nose,' and it represents 1.5 to 15% of all NHLs in the Unit ed Stat es.>' Adva nces in immunohistochemistry have established that most North American and Europea n patients present with type B NHL (55 to 85% of all case s), while subtype T is more common in Asia and in some Lat in American countries, particularly Peru and Guatemala (up to 88% of all casesj.!" It .is still uncl ear whether this differenc e is linked exclus ively to geographic variables or to differences in the specific characteristics of the nasal cavities in vari ous populations; tumors ofthe nasal cavities are mor e common in Asia, as are tumors ofT lineage. "
In terms of sinon asallocalization, NHLs preferentially attack the maxill ary sinuses, ethmoid sinus es, and nasal cavity; prim ary invol vement of the front al sinus is rare. NHLs frequently occur in pat ients with acqui red immunodeficiency syndrome (AIDS), but invol vement of the paranasa l sinuses in these patients is rare ; the most common sites are the central nervous syst em , gastrointestinal tract , and bon e marrow.
In this art icle, we report a case of prim ary type B NHL of the frontal sinu s in a patient with AIDS. We discuss the clinical, diagnostic, therapeutic , and pro gno stic factors related to the management of this typ e 'of patient.
Case report
In Septemb er 1999, we evalu ated a 43-year-old man from Sao Paulo who had been diagno sed with human immun odeficiency viru s (HlV) infection in 1986. He was being treated at an AIDS clinic with saquinavir, ritonavir, and stavudine; his CD4 count was 65 cells/rnm' . He also had a 5-year histo ry of diabetes, which was being cont rolled with an oral hypo glycemic .
One month prior to presentation, the patient began to experience fro ntal headaches that did not respond to common analges ics. The headaches were accompanied by the presence of a pro gressiv e, hard, 15-cm , left frontal bulg ing that invol ved the left upp er eye lid. A few weeks later, a sero sanguineous secretion began to drain from the nasal fossae; he was treated w ith amoxicillin for 10 days but did not improve. He was then referred to our service.
On exam ination, th e pat ient ex hibited the left frontal or bita l bulging and eye lid closure (figu re 1). The orbita l invo lvement had ca used propt osis and chemos is. There was no sign of fluc tuation, but there was light local hyperemia.
Anterior rhinoscopy did not detect any tissue mass in the nasal cavity. However, computed tomography (CT) of the paranasal sin uses revealed that a tum or had filled the left fron ta l sin us, ero ded the roof of the orb it and the floor of the left anterior fossa, and invaded the eye , ethmo id sinus, and left anterior fossa (figure 2). A bio psy speci men was ob tained via a Lynch incision. Examination ofthe speci men revealed that it was a histologicall y high-grade, diffuse N HL wit h large B ce lls. Immunohistochemistry demonstrated positivity for leu kocyte-com mon an tige n (LCA) , CD20 , an d CD45 RO w itho ut atypical lym phocytes, and negat ivity for CD 15 and CD30 .
The patient was sched uled for chemot hera py and a bone marrow biopsy fors tagi ng . However, before these measures co uld be undertaken, he developed clinical co mplications and died in October 1999. Tum ors that origi nate in the nasal fossae ex hibit the immunophenotypic ch aracteristics of type T tum ors, and those that ori gin ate in the paranasal sinuses ex hibit the character istics of type B tumo rs. In our patien t, the findi ng of LCA and CD20 positivity was com patible with a B lineage and wit h origi n in the paranasal sinuses. Of interest, most of these tumors are negative for T-lineage ma rkers such as CD45 RO ,2.3.6but our patient was CD45 RO-positive. Studies have show n that CD45RO ca n be positive in the presence of nor ma l or malignant T ce lls, and they are therefore not highly spec ific for a deter mination of tum or lineage." Lymphomas generally occur in patients in the seventh or eighth decade of life; there is no clear predil ecti on for eit her sex Y·I O .11 Cua dra-Garcia et a l studie d 33 pati ent s w ith large-cell B lymphom a whose age and sex d istr ibution matched th is profi le (mea n age : 63 yr; no pred ilectio n for eit her sex )." However, 2 of these patients were HIV-positive, and both were younger than 50 years, as was ou r pat ient.
Most studies of sinonasa l N HL have show n that the maxill ary sinus is the most co mmo n site of origin,2.6.11 .1 2 followed by the nasal fossae and the ethmo id sinuses .' Primary involvem ent of the fronta l sinus is rare; mo st cases of front al si nus invo lveme nt are secon dary to extension fro m othersinuses. Even so, mos t cases ofsinonasal N HL invo lve more than one sinus , whic h means that determination of the primary site can be somewhat arbitrary.-" According to Sofferman and Cummings" and later Nakamura et al,' a tumor co nfine d excl usive ly to the ethmoid sinus is extrem ely rare. Involvement of the ethmo id sinus is relate d to tumoral ex tension from adjacent sinuses (pr ima rily the maxill ary and frontal sinuses).
Nasal obstruction is the most comm on sy mptom of sinonasal N HL.I.2.6.7.11-13 Edema , fac ial bulgin g, epistax is, a nasal mass, headache, rhinorr hea , prop tosis, paralysis of the crania l nerves, and cavernous sinus syndro me can also occur. According to a study by Lefebvre et a l, low-grade tumors tend to form mas ses in the invo lved nasal ca vity or paranasal sinus and cause nasal obstruction, whereas high-grade tumors cause more agg ressive symptoms , such as fac ial ede ma, ep istaxis , and facia l pain ." Type B lymphomas are usually associated w ith bone destru ction , part icularly in the orbita l region, where they frequ entl y ca use pro ptosis . Typ e T lymphom as rarely cause such sy mptoms . A ltho ug h N HLs ca n infiltra te various sin uses in the face , invo lvement of the ganglia is uncommon. Extension into the orbit, nasopharynx, or se lla turcica may cause symptoms in cranial nerve pairs. Bone erosions are quite com mo n. High-grade B tum ors very ofte n des troy periorbital so ft tiss ue and bone tissue,' as occ urred in our patient. However, bone destruction by a lymphom a is ge nera lly not as aggress ive as that ca used by a spinous ce ll carci noma because the periosteum is Volume 84, Number 1 preserved. " Multiple-si nus involvement is also believed to be associated with bone permeation , ofte n without destruction ofbone divisions.Tomographically, the cond ition man ifests as a mass that has inva ded adjacent soft tissues but has left co rtica l bone intact.
Diagno sis. T he diagnosis ofsino nasa l NHL is base d on a detai led cli nica l history and a complete physical examination. In terms ofimaging exa minations, CT ofthe para nasal sin uses is the best means of identifying the tumor site and extension into the sin uses and orb it. Magnet ic resonance imag ing is also qu ite useful for diagn osing N HLs, especially because it ca n distingui sh between a tumor lesion and mu cosal ede ma or sec retions retain ed in the paranasal sinuses. Mu cosal secretions enhance we ll on T I-weigh ted imaging, whereas tum ors such as lymphom as exhibit moderate enha nce ment on T2-weigh ted imaging.
Biopsy ana lysis can confirm the diagnosis and help determ ine the tumor's lineage. Staging is achieved by chest and abdomen CT, bone gallium scintigraphy, and a bone marrow biopsy.
Tumor classification. Three sys tems have been used to class ify paranasal sinus lymph om as: the Ann Arbor classification," the intern ational histologic classification," and the rev ised Euro pean-A me rican lymphom a (REA L) class ifica tion16; the An n Arbor sys tem is the mos t wide ly used (table I) .
Most sinonasal N HLs present as stage I tumors, although the incidence ofhigher-stage tumors is significant. 1.7.1 I Our patient died before we were able to complete the staging process.
Treatm ent. Treatment is controversia l with rega rd to the best co mbinat ion of treat me nts for these patients. (table 2) . 5, 6, [8] [9] [10] [11] 17, 20 Reported survi val rates vary widely; these variations are att ributable in part to the relative rarity of paranasal NHL.
Shima et al studied 14 patients with NHL of the sinonasal tract and reported a 5-year sur vival rate of 85% for tumors of the paranasal sinuses (ma xillary and ethmoid) and a 5-year rate of 25 % for tumors of the nasa l cavity." Patients with B-lineage tumors had a 5-year survi val rate of 61%, compared with on ly 12% for patients with T-lineage tumors. These authors found no statistically significant differences in survival between patients with stage I and stage II disease and between patients who underwent different types of treatment.
In a series of20 patients with sinonasal NHL, Kojima et al found that patients whose tumor involved only the paranasal sinuses had a higher 5-year survival rate than did patients with invol vement of both the nas al cavity and paranasal sinuses."
In other studies, Frierson et al studied II patients with sinonasal NHL and reported that 6 died between I and 43 months after diagnosis; 3 of these pat ients presented with stage III or IV disease.11 Nakamura et al evaluated 24 pat ients with stage I or II disease and reported 5-year survi val rates of64% for patients with tumors of the nasal cavity and 75% for those with tum ors of the parana sal 
